Publications:71
Video Visit Available
Accepting New Patients
Mount Sinai DoctorsTreats Adults
Accepting New PatientsMarina Kremyanskaya, MD PhD
Internal Medicine, Cancer (Oncology), Hematology-Oncology
No Patient Experience Ratings
Book an Appointment
About Me
Marina Kremyanskaya, MD, PhD, is an Associate Professor of Medicine, Hematology and Medical Oncology, at the Icahn School of Medicine at Mount Sinai. She serves as the medical director for the inpatient oncology unit at The Mount Sinai Hospital, where she provides medical oversight in the management of hospitalized cancer patients. Dr. Kremyanskaya’s clinical focus is on acute myeloid leukemia (AML) and other myeloid malignancies such as myeloproliferative neoplasm (MPN), myelodysplastic syndromes (MDS), chronic myeloid leukemia (CML), and other myeloid blood cancers.
She works as a part of a multidisciplinary team to provide high quality, patient-centered care and to ensure the best possible outcomes. Dr. Kremyanskaya is actively involved in the development of novel therapies for patients with MPN and AML, and is leading numerous clinical trials investigating better treatment options for these relatively rare conditions. She has authored multiple peer-reviewed publications and book chapters.
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Cancer, Leukemia
About Me
Marina Kremyanskaya, MD, PhD, is an Associate Professor of Medicine, Hematology and Medical Oncology, at the Icahn School of Medicine at Mount Sinai. She serves as the medical director for the inpatient oncology unit at The Mount Sinai Hospital, where she provides medical oversight in the management of hospitalized cancer patients. Dr. Kremyanskaya’s clinical focus is on acute myeloid leukemia (AML) and other myeloid malignancies such as myeloproliferative neoplasm (MPN), myelodysplastic syndromes (MDS), chronic myeloid leukemia (CML), and other myeloid blood cancers.
She works as a part of a multidisciplinary team to provide high quality, patient-centered care and to ensure the best possible outcomes. Dr. Kremyanskaya is actively involved in the development of novel therapies for patients with MPN and AML, and is leading numerous clinical trials investigating better treatment options for these relatively rare conditions. She has authored multiple peer-reviewed publications and book chapters.
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Cancer, Leukemia